Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Clinical trial NCT01535053 · COMPLETED

Trial details

NCT number: NCT01535053
Sponsor: GOG Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Choriocarcinoma FIGO Stage I Gestational Trophoblastic Tumor FIGO Stage II Gestational Trophoblastic Tumor FIGO Stage III Gestational Trophoblastic Tumor Hydatidiform Mole

Start date: 2012-06-18
Primary completion: 2018-05-31
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.